ERLIN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.342600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.853200E-01
Normal-vs-Stage2
2.875800E-01
Normal-vs-Stage3
3.079000E-01
Normal-vs-Stage4
1.167580E-01
Stage1-vs-Stage2
5.869200E-01
Stage1-vs-Stage3
1.061160E-01
Stage1-vs-Stage4
4.510800E-01
Stage2-vs-Stage3
6.254000E-02
Stage2-vs-Stage4
8.161800E-01
Stage3-vs-Stage4
3.216100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.692000E-01
Normal-vs-AfricanAmerican
1.563380E-01
Normal-vs-Asian
2.799200E-01
Caucasian-vs-AfricanAmerican
9.534600E-01
Caucasian-vs-Asian
6.168200E-01
AfricanAmerican-vs-Asian
6.877400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.029200E-01
Normal-vs-Female
3.846600E-01
Male-vs-Female
6.901700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.330200E-01
Normal-vs-Age(41-60Yrs)
1.803370E-01
Normal-vs-Age(61-80Yrs)
4.437400E-01
Normal-vs-Age(81-100Yrs)
2.741200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.755200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.168200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.925800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.452400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.972400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.960600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.992000E-01
Normal-vs-Daily Drinker
3.384400E-01
Normal-vs-Weekly Drinker
1.793850E-01
Normal-vs-Occasional Drinker
1.462380E-01
Normal-vs-Social Drinker
4.173400E-01
Non Drinker-vs-Daily Drinker
4.451800E-01
Non Drinker-vs-Weekly Drinker
5.564800E-01
Non Drinker-vs-Occasional Drinker
7.386000E-02
Non Drinker-vs-Social Drinker
3.903800E-01
Daily Drinker-vs-Weekly Drinker
8.801400E-01
Daily Drinker-vs-Occasional Drinker
3.304600E-01
Daily Drinker-vs-Social Drinker
8.148600E-01
Weekly Drinker-vs-Occasional Drinker
6.151600E-01
Weekly Drinker-vs-Social Drinker
9.763200E-01
Occasional Drinker-vs-Social Drinker
5.925000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.823600E-01
Normal-vs-Grade 2
3.726100E-02
Normal-vs-Grade 3
7.401500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.839100E-04
Grade 1-vs-Grade 3
2.47979999999925E-05
Grade 1-vs-Grade 4
2.823600E-01
Grade 2-vs-Grade 3
2.117800E-02
Grade 2-vs-Grade 4
3.726100E-02
Grade 3-vs-Grade 4
7.401500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.986000E-01
Normal-vs-NonDiabetic
3.356000E-01
Diabetic-vs-NonDiabetic
7.824600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.715620E-01
Normal-vs-NoPancreatitis
4.003400E-01
Pancreatitis-vs-NoPancreatitis
2.041600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.143800E-01
Normal-vs-N1
3.282400E-01
N0-vs-N1
9.215600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.121900E-03
Normal-vs-TP53-NonMutant
2.176000E-02
TP53-Mutant-vs-TP53-NonMutant
7.368000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
